We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Medical complications of obesity
- Obesity is the primary risk factor for diabetes
- Age-adjusted prevalence of hypertension vs. BMI
- Metabolic syndrome: clinical identification
- Twin epidemics: parallels in prevalence
- Obesity and coronary heart disease mortality
- Intentional weight loss and its health benefits
- Data supporting life-style intervention
- Weight loss and cardiovascular risk
- US diabetes prevention program
- Study interventions
- Characteristics by treatment group assignment
- DPP: lifestyle intervention
- Dietary factors that affect energy intake
- Weight-Reducing diet - recommended nutrients
- DPP: effect of interventions on weight
- DPP: mean change in leisure physical activity
- DPP: cumulative incidence of diabetes
- Mean change in blood pressure
- Mean change in lipids (1)
- Mean change in lipids (2)
- Thrombogenic and inflammatory risk
- Mean change in TPA
- Mean change in fibrinogen
- Mean change in CRP
- CRP levels in obese postmenopausal women
- Finnish diabetes prevention study
- FDPS: goals of intervention
- FDPS: effect of interventions on weight
- FDPS: prevention of diabetes
- FDPS: changes in clinical and metabolic variables
- Hazard rate for diabetes and the change in weight
- DPP and FDPS conclusions
- LookAHEAD trial (1)
- Look AHEAD trial (2)
- Baseline characteristics of participants
- LookAHEAD interventions
- LookAHEAD: weight loss at 1-year
- LookAHEAD: fitness change at 1-year
- LookAHEAD: glycemia outcomes
- LookAHEAD: blood pressure outcomes
- LookAHEAD: lipid outcomes
- LookAHEAD: other outcomes
- LookAHEAD: conclusions
- Trials of hypertension prevention, phase II
- TOHP II: effect of intervention on weight
- TOHP II: mean change in blood pressure
- Effects of population-based BP reduction
- Effect of modest weight loss on cholesterol
- Effect of weight loss on HDL-C in type 2 diabetes
- Weight loss: mechanisms for improvement in risks
- Adipose tissue as endocrine cells
- Obesity as a therapeutic target for prevention
- Cancer incidence attributable to obesity
- All cause mortality
- Thank you
Topics Covered
- Medical complications of obesity
- Obesity is the primary risk factor for diabetes
- Age-adjusted prevalence of hypertension vs. BMI
- Metabolic syndrome: clinical identification
- Obesity and coronary heart disease mortality
- Data supporting life-style intervention
- Weight loss and cardiovascular risk
- US diabetes prevention program
- Study interventions
- DPP: lifestyle intervention
- Dietary factors that affect energy intake
- Weight-Reducing diet
- recommended nutrients
- Mean change in blood pressure
- Mean change in lipids
- Thrombogenic and inflammatory risk
- Mean change in TPA
- Mean change in fibrinogen
- Mean change in CRP
- Finnish diabetes prevention study
- Hazard rate for diabetes and the change in weight
- LookAHEAD trial
- Trials of hypertension prevention, phase II
- Effects of population-based BP reduction
- Effect of modest weight loss on cholesterol
- Adipose tissue as endocrine cells
- Obesity as a therapeutic target for prevention
- Cancer incidence attributable to obesity
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Pi-Sunyer, X. (2009, May 31). Health benefits of intentional weight loss [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 1, 2024, from https://doi.org/10.69645/KYDT9407.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Xavier Pi-Sunyer has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.